(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NYSE:REGN) has seen a 6.99% increase in short interest since its last report, with 1.40 million shares sold short, representing 1.53% of its float. The average time to cover these short positions is 2.32 days. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop. Compared to its peers, REGN has a lower short interest as a percentage of float, with the peer group average at 5.43%.
December 11, 2023 | 2:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Regeneron Pharmaceuticals has experienced an increase in short interest, which could indicate bearish sentiment among investors. However, its short interest is still below the peer group average, suggesting less negative sentiment compared to its peers.
The increase in short interest for Regeneron Pharmaceuticals may suggest that some investors are expecting the stock price to decline. However, since the short interest is lower than the peer group average, it does not strongly indicate a widespread negative outlook. The impact on the stock price in the short term is uncertain, as short interest is just one of many factors that can affect stock prices.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100